Quadrant Capital Group LLC Summit Therapeutics Inc. Transaction History

Quadrant Capital Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$1.32 - $2.81 $233 - $497	177 New	177 $0
Q4 2021 Feb 01, 2022	SELL	$2.45 - $5.64 $2,075 - $4,777	-847 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$4.83 - $8.27 $2,255 - $3,862	467 Added 122.89%	847 $4,000
Q2 2021 Aug 09, 2021	SELL	$5.15 - $8.46 $932 - $1,531	-181 Reduced 32.26%	380 $3,000
Q1 2021 May 12, 2021	BUY	$5.17 - $11.19 $1,070 - $2,316	207 Added 58.47%	561 $3,000
Q4 2020 Feb 16, 2021	BUY	$3.25 - $6.0 $1,150 - $2,124	354 New	354 $2,000

211

76.5M

2.83M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $4.05B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.